𝔖 Bobbio Scriptorium
✦   LIBER   ✦

p53 Mutations are present in colorectal cancer with cytoplasmic p53 accumulation

✍ Scribed by Agneta Jansson; Massimiliano Gentile; Xiao-Feng Sun

Publisher
John Wiley and Sons
Year
2001
Tongue
French
Weight
401 KB
Volume
92
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Previous studies have shown that nuclear p53 over-expression is an indicator of p53 mutations whereas cytoplasmic p53 accumulation is related to wild-type p53 in several kinds of tumors. Cytoplasmic p53 accumulation has been demonstrated to be an independent prognostic factor in colorectal adenocarcinomas. The purpose was to examine whether mutations occur in cases with p53 accumulated in the cytoplasm and whether there are any differences in the frequency and characteristics of p53 mutations in different staining patterns. In the present study, we identified p53 mutations using PCR single-strand conformation polymorphism (SSCP) and DNA sequencing in 75 primary colorectal adenocarcinomas with different staining patterns (negative, nucleus, cytoplasm, nucleus and cytoplasm). The results show that the frequency and nature of mutations in tumors with cytoplasmic p53 accumulation were similar to those with nuclear p53 expression. However, the tumors with accumulation in both the nucleus and cytoplasm demonstrated a higher mutation rate. We suppose that the role of cytoplasmic p53 accumulation in predicting prognosis in patients with colorectal cancer may be dependent on both mutational and non-mutational mechanisms.

πŸ“œ SIMILAR VOLUMES

Correlations between p53-protein accumul
Correlations between p53-protein accumulation, serum antibodies and gene mutation in colorectal cancer
✍ Pascal Hammel; Karen Leroy-Viard; Marie-ThΓ©rΓ¨se Chaumette; Jacqueline Villaudy; πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 254 KB πŸ‘ 1 views

Only half of colorectal-cancer patients elicit serum antibodies in response to intratumoral p53-gene mutations. Our study was designed to compare cellular events (p53-protein accumulation and gene mutations) with the presence of circulating anti-p53 antibodies (p53-Ab). Thirty-five colorectalcancer

Conserved region mutations of the p53 ge
Conserved region mutations of the p53 gene are concentrated in distal colorectal cancers
✍ Petra Jernvall; Markus MΓ€kinen; Tuomo Karttunen; Jyrki MΓ€kelΓ€; Pirkko Vihko πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 247 KB πŸ‘ 2 views

Distal colorectal cancers, especially those in the rectum, are more aggressive and more commonly recurrent than proximal cancers. We studied the possible relationship between p53-gene mutation type and location of the tumour, since mutations in the conserved areas of the p53 gene have been suggested

p53 mutations in human bladder cancer
p53 mutations in human bladder cancer
✍ Wolfgang C. Kusser; Xili Miao; Barry W. Glickman; Joan M. Friedland; Nathaniel R πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 484 KB
K-ras and p53 mutations in hereditary no
K-ras and p53 mutations in hereditary non-polyposis colorectal cancers
✍ Lorena Losi; Maurizio Ponz de Leon; Josef Jiricny; Carmela Di Gregorio; Piero Be πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 57 KB πŸ‘ 2 views

Genetic instability related to defective DNA mismatch repair genes may be involved in the pathogenesis of carcinoma in Hereditary Non-Polyposis Colorectal Cancer (HN-PCC). To test that the targets of genetic instability could include critical transforming genes involved in colon tumor progression, w

Combination of p53 codon 72 polymorphism
Combination of p53 codon 72 polymorphism and inactive p53 mutation predicts chemosensitivity to 5-fluorouracil in colorectal cancer
✍ Toshiji Tominaga; Makoto Iwahashi; Katsunari Takifuji; Tsukasa Hotta; Shozo Yoko πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 272 KB

## Abstract There are increasing reports showing the clinical significance of the __p53__ polymorphism status in terms of the response to chemotherapy. We investigated whether __p53__ polymorphism and mutation were associated with __in vitro__ sensitivity to 5‐fluorouracil (5‐FU) in patients with c